AURKA and non-small cell lung carcinoma: revealed that activating aurora kinase A (AURKA) in the TKI‐exposed DTCs from EGFR‐mutant NSCLC inhibits drug‐mediated apoptosis by enhancing the phosphorylation and degradation of BIM.